Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Europe’s EV Boom Was Real in 2025. The Real Fight Starts In 2026 - 2Politics at the table? Drinking the wine you brought? An etiquette expert's Thanksgiving dos and don'ts.
- 34 Jeep Models: Dominating Execution and Flexibility for Each Experience
- 4The Latest: Fueling begins as NASA aims to send 1st crew to the moon in 53 years
- 5Eating ultra-processed foods could raise precancerous polyp risk for women under 50, according to research
- Strength training is crucial after menopause. How to make the most of your workouts
- 'The Golden Bachelor' Season 2 finale: How to watch tonight, start time, where to stream and more
- Moderna to complete US mRNA manufacturing network with $140 million investment
- Online business Stages for Little Retailers
- First foreign troop in new gang suppression force lands in Haiti to replace previous mission
- Step by step instructions to Guarantee Your Lab Precious stone is Morally Obtained
- Hezbollah fires over 600 times at Israel, IDF troops over last 24 hours
- Taylor Frankie Paul's domestic violence case is fueling discussions about DARVO. Experts say terms like this shouldn't be used lightly.
- Interstellar comet 3I/ATLAS reveals weird wobbling jets in rare sun-facing tail
